Glancy Donovan Michael — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Glancy Donovan Michael has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Profile
The SEC filing context lists Glancy Donovan Michael in relation to Collegium Pharmaceutical, Inc. as of 2026-05-18. Public disclosures for Collegium indicate this individual is an insider (potential director or executive) of the company. There is limited publicly available biographical information tied to this exact naming variant in SEC filings or standard leadership bios. Given the possibility of name variations (e.g., Michael Glancy Donovan, John R. Joyce, etc.) and potential name collisions, a precise background (education, prior roles, and current title) cannot be confirmed from the provided context alone. Cross-checking the company’s Form 4/8-K disclosures or leadership/board bios is recommended to establish the exact role and background.
Role
Insider
Notability
20/100
Board memberships
Collegium Pharmaceutical, Inc
Awards & honors
Listed in SEC filings as associated with Collegium Pharmaceutical, Inc. (as of 2026-05-18)
The SEC filing context lists Glancy Donovan Michael in relation to Collegium Pharmaceutical, Inc. as of 2026-05-18. Public disclosures for Collegium indicate this individual is an insider (potential director or executive) of the company. There is limited publicly available biographical information tied to this exact naming variant in SEC filings or standard leadership bios. Giv…
How many SEC Form 4 filings has Glancy Donovan Michael submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Glancy Donovan Michael's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
